CRISPR Therapeutics AG
$55.67
24H
Market Cap
Volume
Supply
Price Chart
About CRISPR Therapeutics AG - CRSP
CRISPR Therapeutics AG is a biotechnology company focused on developing gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. It was co-founded by one of the pioneers of CRISPR technology, Dr. Emmanuelle Charpentier.
What are CRISPR Therapeutics AG's core values and mission statement?
CRISPR Therapeutics AG's mission is generally to develop transformative gene-based medicines for serious human diseases. Their core values focus on scientific innovation, integrity, urgency, and collaboration to achieve this mission.
Who founded CRISPR Therapeutics AG and when?
CRISPR Therapeutics AG was co-founded by Emmanuelle Charpentier, along with Rodger Novak and Shaun Foy in 2013.
Who leads CRISPR Therapeutics AG?
As of the latest available information, Samarth Kulkarni serves as the CEO of CRISPR Therapeutics AG.
Where is CRISPR Therapeutics AG located, and what is its base country?
CRISPR Therapeutics AG is headquartered in Zug, Switzerland, which is also its base country.
On which exchanges is CRISPR Therapeutics AG traded?
CRISPR Therapeutics AG is traded on the NASDAQ under the ticker symbol CRSP.
Historical data
CRISPR Therapeutics AG (CRSP) Price Live Data
The live price of CRISPR Therapeutics AG (CRSP) is $55.67, with a trading volume of 892,184 in the last 24 hours. Wrapstocks updates the CRSP price in real-time. CRISPR Therapeutics AG is up 1.13% in the last 24 hours. The company has a live market cap of $4,725,442,048.00 and a supply of 84,883,098 CRSP stocks.
CRISPR Therapeutics AG (CRSP) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 51 minutes.
